Company news
Recce Pharmaceuticals Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Operational Update and Quarterly Cash Flow
January 30, 2017
Lead compound reduces illness in mice infected by E.coli
January 17, 2017
Encouraging anti-viral activity for lead compound RECCE 327
December 20, 2016
Pre-clinical toxicology and efficacy testing
November 2, 2016
Dose Ranging in Mice - Repeated Success
August 15, 2016
Successful Test Results for Genetic Toxicity
July 20, 2016
Anti-viral Activity
July 13, 2016
Update on Testing Schedules
June 20, 2016
Encouraging Results from Safety Test
May 25, 2016
Recce - The Way Forward
May 2, 2016
Progress Update
April 10, 2016
International Trade Mark Registrations
April 5, 2016
Anti-cancer Activities
March 13, 2016
Appendix 4D and Half Year Financial Statements
February 26, 2016
Efficacy without Toxicity
February 11, 2016
RECCE Antibiotic kills TB and Gonorrhoea
February 10, 2016
Patent Granted in China
February 10, 2016
Admission to Official List
February 10, 2016
Additional Patent Developments
February 10, 2016
Decks
The 5 newest of 45 decks. Every deck is listed under its year.
- Shareholder Meeting (November 2026)
Shareholder meeting · 19 slides · Nov 6, 2026
- Investor Presentation (November 2026)
Investor deck · 45 slides · November 2026
- Investor Presentation (October 2026)
Investor deck · 42 slides · October 2026
- Shareholder Meeting (September 2026)
Shareholder meeting · 10 slides · Sep 2, 2026
- Investor Presentation (September 2026)
Investor deck · 42 slides · September 2026